AbstractBackgroundPlozasiran, an investigational siRNA targeting hepatic apoC-III, reduces triglyceride-rich lipoproteins (TRLs). The impact of plozasiran on lipoprotein particle numbers and sizes …
“Eddington,” while not a comedy, presents an angry, sinister, and maybe crazy new America that it views with a deadpan tone of trepidatious glee. And…
This case-control of older US adults examines risk of Parkinson Disease by proximity of residence to a golf course.
Read our coverage of the major medical conferences that impact thoracic oncologists and surgeons.
The last 2 decades have seen a paradigm shift in the treatment landscape of metastatic gastric and gastroesophageal adenocarcinomas, with most of the progress occurring…
Results from the phase 1b study suggest venetoclax plus modified chemotherapy is an effective and well-tolerated approach.
Immunotherapy for Urothelial Cancer: Types, Success Rate, Side Effects and More
This JAMA Internal Medicine Patient Page describes the process of slowly and carefully cutting down on unnecessary medications with the guidance of a health care…
A study examined one medical center’s adherence to gout management guidelines regarding the use of urate-lowering therapy (ULT) to lower uric acid (UA) levels.
AbstractBackgroundPeak creatine kinase-MB (CK-MB) level is an established predictor of clinical outcomes following acute myocardial infarction (AMI). However, the significance of the duration betwe…
Takotsubo cardiomyopathy continues to be a major cause of mortality and morbidity. The goal of this study was to evaluate the outcome data of patients…
